As described above, Reiter and colleagues have reported that N-cadherin could cause metastasis and castration resistance of prostate cancer, but antibodies blocking N-cadherin not only delay the progression of prostate cancer to castration resistance but also inhibit invasion, metastasis and castration-resistant tumor growth in vitro and in vivo[12]. Here, CDH2 is linked to prostate cancer.